(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNOSPOT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

IMMUNOSPOT

ST13

US500000075609039

Class

5, 9, 10

Filing

75609039

Registration

2460772

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

10/30/2020

Trademark type

Combined

Nice classes

5, 9, 10

Filing date

12/21/1998

Registration date

06/19/2001

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/30/2020

Last transaction

10/30/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1998-02-00

First use in commerce

1998-02-00

Drawing code

3

Owner type

16

Owner location

Shaker Heights, OH

Examiner

MCMORROW, RONALD

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Cellular Technology Limited
Cellular Technology Limited

Representatives

D. BENJMIN BORSON, Ph.D. BORSON LAW GROUP PC

Technical classification

Nice Classes

Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

MEDICAL DIAGNOSTIC KITS COMPRISED OF REAGENTS AND ASSAY PLATES FOR CLINICAL OR MEDICAL LABORATORY USE

Class 9

LABORATORY EQUIPMENTAUTOMATED IMMUNOASSAY ANALYZERS AND PARTS THEREFORE FOR SCIENTIFIC RESEARCH

Class 10

MEDICAL EQUIPMENTAUTOMATED IMMUNOASSAY ANALYZERS AND PARTS THEREFOR FOR MEDICAL USE AND MEDICAL RESEARCH

Publications

History of USPTO decisions and trademark events.

24 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/30/2020

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/30/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/30/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/17/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

08/31/2020

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

05/01/2012

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

05/01/2012

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

05/01/2012

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

06/16/2011

MAIL

PAPER RECEIVED

06/16/2011

CORV

REVIEW OF CORRESPONDENCE COMPLETE

07/20/2009

FAXX

FAX RECEIVED

05/29/2009

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

11/28/2007

PLGL

ASSIGNED TO PARALEGAL

11/26/2007

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

11/16/2007

MAIL

PAPER RECEIVED

11/16/2007

CFIT

CASE FILE IN TICRS

10/10/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

06/19/2001

PUBO

PUBLISHED FOR OPPOSITION

03/27/2001

NPUB

NOTICE OF PUBLICATION

03/14/2001

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/14/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/24/2000

CNRT

NON-FINAL ACTION MAILED

01/24/2000

DOCK

ASSIGNED TO EXAMINER

01/18/2000

Continuous trademark protection

Get notified about every new filing that threatens IMMUNOSPOT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.